Kubesch, A., Lande, R., Leutgöb, A., Farrag, K., Dahmer, I., Stratmann-Vollrath, K., Dienethal, A., Michael, F. A., Sprinzl, K., Zeuzem, S., Blumenstein, I. (2025). Sequencing Therapy for Optimal Response in Mirikizumab (STORM)-study: A tertiary referral center study on patients with therapy-refractory ulcerative colitis. PLoS ONE. https://doi.org/10.1371/journal.pone.0334897